List of Tables
    Table 1. Cancer Pain CAGR in Value, United States VS Global, 2017 VS 2022 VS 2028
    Table 2. Cancer Pain Market Trends
    Table 3. Cancer Pain Market Drivers
    Table 4. Cancer Pain Market Challenges
    Table 5. Cancer Pain Market Restraints
    Table 6. Global Cancer Pain Sales by Type: 2017 VS 2022 VS 2028 (US$ Million)
    Table 7. United States Cancer Pain Sales by Type: 2017 VS 2022 VS 2028 (US$ Million)
    Table 8. Global Cancer Pain Sales by Application: 2017 VS 2022 VS 2028 (US$ Million)
    Table 9. United States Cancer Pain Sales by Application: 2017 VS 2022 VS 2028 (US$ Million)
    Table 10. Top Cancer Pain Manufacturers in Global Market, Ranking by Revenue (2021)
    Table 11. Global Cancer Pain Revenue by Manufacturer, (US$ Million), 2017-2022
    Table 12. Global Cancer Pain Revenue Share by Manufacturer, 2017-2022
    Table 13. Global Cancer Pain Sales by Manufacturer, (K Units), 2017-2022
    Table 14. Global Cancer Pain Sales Share by Manufacturer, 2017-2022
    Table 15. Global Cancer Pain Price by Manufacturer (2017-2022) & (USD/Unit)
    Table 16. Global Cancer Pain Manufacturers Market Concentration Ratio (CR5 and HHI)
    Table 17. Global Cancer Pain by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Cancer Pain as of 2021)
    Table 18. Top Players of Cancer Pain in Global Market, Headquarters and Distribution of Producing Region
    Table 19. Manufacturers Cancer Pain Product Type
    Table 20. Date of International Manufacturers Enter into Cancer Pain Market
    Table 21. Manufacturers Mergers & Acquisitions, Expansion Plans
    Table 22. Top Cancer Pain Players in United States Market, Ranking by Revenue (2021)
    Table 23. United States Cancer Pain Revenue by Players, (US$ Million), 2020, 2021 & 2022
    Table 24. United States Cancer Pain Revenue Share by Players, 2020, 2021 & 2022
    Table 25. United States Cancer Pain Sales by Players, (K Units), 2020, 2021 & 2022
    Table 26. United States Cancer Pain Sales Share by Players, 2020, 2021 & 2022
    Table 27. Global Cancer Pain Market Size by Region (US$ Million): 2017 VS 2022 VS 2028
    Table 28. Global Cancer Pain Sales in Volume by Region (2017-2022) & (K Units)
    Table 29. Global Cancer Pain Sales in Volume Forecast by Region (2023-2028) & (K Units)
    Table 30. Global Cancer Pain Sales in Value by Region (2017-2022) & (US$ Million)
    Table 31. Global Cancer Pain Sales in Value Forecast by Region (2023-2028) & (US$ Million)
    Table 32. North America Cancer Pain Sales in Volume by Country (2017-2028) & (K Units)
    Table 33. North America Cancer Pain Sales in Value by Country (2017-2028) & (US$ Million)
    Table 34. Asia Pacific Cancer Pain Sales in Volume by Region (2017-2028) & (K Units)
    Table 35. Asia Pacific Cancer Pain Sales in Value by Region (2017-2028) & (US$ Million)
    Table 36. Europe Cancer Pain Sales in Volume by Country (2017-2028) & (K Units)
    Table 37. Europe Cancer Pain Sales in Value by Country (2017-2028) & (US$ Million)
    Table 38. Latin America Cancer Pain Sales in Volume by Country (2017-2028) & (K Units)
    Table 39. Latin Americaa Cancer Pain Sales in Value by Country (2017-2028) & (US$ Million)
    Table 40. Middle East and Africa Cancer Pain Sales in Volume by Country (2017-2028) & (K Units)
    Table 41. Middle East and Africa Cancer Pain Sales in Value by Country (2017-2028) & (US$ Million)
    Table 42. BioDelivery Science Corporation Information
    Table 43. BioDelivery Science Description and Business Overview
    Table 44. BioDelivery Science Cancer Pain Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2017-2022)
    Table 45. BioDelivery Science Cancer Pain Product
    Table 46. BioDelivery Science Recent Development
    Table 47. ProStrakan Group Corporation Information
    Table 48. ProStrakan Group Description and Business Overview
    Table 49. ProStrakan Group Cancer Pain Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2017-2022)
    Table 50. ProStrakan Group Product
    Table 51. ProStrakan Group Recent Development
    Table 52. Teva pharmaceuticals Corporation Information
    Table 53. Teva pharmaceuticals Description and Business Overview
    Table 54. Teva pharmaceuticals Cancer Pain Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2017-2022)
    Table 55. Teva pharmaceuticals Product
    Table 56. Teva pharmaceuticals Recent Development
    Table 57. Eli-Lilly Corporation Information
    Table 58. Eli-Lilly Description and Business Overview
    Table 59. Eli-Lilly Cancer Pain Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2017-2022)
    Table 60. Eli-Lilly Product
    Table 61. Eli-Lilly Recent Development
    Table 62. Grunenthal Group Corporation Information
    Table 63. Grunenthal Group Description and Business Overview
    Table 64. Grunenthal Group Cancer Pain Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2017-2022)
    Table 65. Grunenthal Group Product
    Table 66. Grunenthal Group Recent Development
    Table 67. GW Pharmaceuticals Corporation Information
    Table 68. GW Pharmaceuticals Description and Business Overview
    Table 69. GW Pharmaceuticals Cancer Pain Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2017-2022)
    Table 70. GW Pharmaceuticals Product
    Table 71. GW Pharmaceuticals Recent Development
    Table 72. Johnson＆Johnson Corporation Information
    Table 73. Johnson＆Johnson Description and Business Overview
    Table 74. Johnson＆Johnson Cancer Pain Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2017-2022)
    Table 75. Johnson＆Johnson Product
    Table 76. Johnson＆Johnson Recent Development
    Table 77. Meda Pharmaceuticals Corporation Information
    Table 78. Meda Pharmaceuticals Description and Business Overview
    Table 79. Meda Pharmaceuticals Cancer Pain Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2017-2022)
    Table 80. Meda Pharmaceuticals Product
    Table 81. Meda Pharmaceuticals Recent Development
    Table 82. Orexo Corporation Information
    Table 83. Orexo Description and Business Overview
    Table 84. Orexo Cancer Pain Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2017-2022)
    Table 85. Orexo Product
    Table 86. Orexo Recent Development
    Table 87. Sanofi Corporation Information
    Table 88. Sanofi Description and Business Overview
    Table 89. Sanofi Cancer Pain Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2017-2022)
    Table 90. Sanofi Product
    Table 91. Sanofi Recent Development
    Table 92. WEX Pharmaceuticals Corporation Information
    Table 93. WEX Pharmaceuticals Description and Business Overview
    Table 94. WEX Pharmaceuticals Cancer Pain Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2017-2022)
    Table 95. WEX Pharmaceuticals Product
    Table 96. WEX Pharmaceuticals Recent Development
    Table 97. Key Raw Materials Lists
    Table 98. Raw Materials Key Suppliers Lists
    Table 99. Cancer Pain Customers List
    Table 100. Cancer Pain Distributors List
    Table 101. Research Programs/Design for This Report
    Table 102. Key Data Information from Secondary Sources
    Table 103. Key Data Information from Primary Sources
List of Figures
    Figure 1. Cancer Pain Product Picture
    Figure 2. Global Cancer Pain Revenue, (US$ Million), 2017 VS 2022 VS 2028
    Figure 3. Global Cancer Pain Market Size 2017-2028 (US$ Million)
    Figure 4. Global Cancer Pain Sales 2017-2028 (K Units)
    Figure 5. United States Cancer Pain Revenue, (US$ Million), 2017 VS 2022 VS 2028
    Figure 6. United States Cancer Pain Market Size 2017-2028 (US$ Million)
    Figure 7. United States Cancer Pain Sales 2017-2028 (K Units)
    Figure 8. United States Cancer Pain Market Share in Global, in Value (US$ Million) 2017-2028
    Figure 9. United States Cancer Pain Market Share in Global, in Volume (K Units) 2017-2028
    Figure 10. Cancer Pain Report Years Considered
    Figure 11. Product Picture of Opioids
    Figure 12. Product Picture of Non-Steroidal Anti-Inflammatory Drugs
    Figure 13. Product Picture of Others
    Figure 14. Global Cancer Pain Market Share by Type in 2022 & 2028
    Figure 15. Global Cancer Pain Sales in Value by Type (2017-2028) & (US$ Million)
    Figure 16. Global Cancer Pain Sales Market Share in Value by Type (2017-2028)
    Figure 17. Global Cancer Pain Sales by Type (2017-2028) & (K Units)
    Figure 18. Global Cancer Pain Sales Market Share in Volume by Type (2017-2028)
    Figure 19. Global Cancer Pain Price by Type (2017-2028) & (USD/Unit)
    Figure 20. United States Cancer Pain Market Share by Type in 2022 & 2028
    Figure 21. United States Cancer Pain Sales in Value by Type (2017-2028) & (US$ Million)
    Figure 22. United States Cancer Pain Sales Market Share in Value by Type (2017-2028)
    Figure 23. United States Cancer Pain Sales by Type (2017-2028) & (K Units)
    Figure 24. United States Cancer Pain Sales Market Share in Volume by Type (2017-2028)
    Figure 25. United States Cancer Pain Price by Type (2017-2028) & (USD/Unit)
    Figure 26. Product Picture of Radiotherapy
    Figure 27. Product Picture of Chemotherapy
    Figure 28. Product Picture of Hormone Therapy
    Figure 29. Product Picture of Others
    Figure 30. Global Cancer Pain Market Share by Application in 2022 & 2028
    Figure 31. Global Cancer Pain Sales in Value by Application (2017-2028) & (US$ Million)
    Figure 32. Global Cancer Pain Sales Market Share in Value by Application (2017-2028)
    Figure 33. Global Cancer Pain Sales by Application (2017-2028) & (K Units)
    Figure 34. Global Cancer Pain Sales Market Share in Volume by Application (2017-2028)
    Figure 35. Global Cancer Pain Price by Application (2017-2028) & (USD/Unit)
    Figure 36. United States Cancer Pain Market Share by Application in 2022 & 2028
    Figure 37. United States Cancer Pain Sales in Value by Application (2017-2028) & (US$ Million)
    Figure 38. United States Cancer Pain Sales Market Share in Value by Application (2017-2028)
    Figure 39. United States Cancer Pain Sales by Application (2017-2028) & (K Units)
    Figure 40. United States Cancer Pain Sales Market Share in Volume by Application (2017-2028)
    Figure 41. United States Cancer Pain Price by Application (2017-2028) & (USD/Unit)
    Figure 42. North America Cancer Pain Sales in Volume Growth Rate 2017-2028 (K Units)
    Figure 43. North America Cancer Pain Sales in Value Growth Rate 2017-2028 (US$ Million)
    Figure 44. U.S. Cancer Pain Sales in Value Growth Rate (2017-2028) & (US$ Million)
    Figure 45. Canada Cancer Pain Sales in Value Growth Rate (2017-2028) & (US$ Million)
    Figure 46. Europe Cancer Pain Sales in Volume Growth Rate 2017-2028 (K Units)
    Figure 47. Europe Cancer Pain Sales in Value Growth Rate 2017-2028 (US$ Million)
    Figure 48. Germany Cancer Pain Sales in Value Growth Rate (2017-2028) & (US$ Million)
    Figure 49. France Cancer Pain Sales in Value Growth Rate (2017-2028) & (US$ Million)
    Figure 50. U.K. Cancer Pain Sales in Value Growth Rate (2017-2028) & (US$ Million)
    Figure 51. Italy Cancer Pain Sales in Value Growth Rate (2017-2028) & (US$ Million)
    Figure 52. Russia Cancer Pain Sales in Value Growth Rate (2017-2028) & (US$ Million)
    Figure 53. Asia-Pacific Cancer Pain Sales in Volume Growth Rate 2017-2028 (K Units)
    Figure 54. Asia-Pacific Cancer Pain Sales in Value Growth Rate 2017-2028 (US$ Million)
    Figure 55. China Cancer Pain Sales in Value Growth Rate (2017-2028) & (US$ Million)
    Figure 56. Japan Cancer Pain Sales in Value Growth Rate (2017-2028) & (US$ Million)
    Figure 57. South Korea Cancer Pain Sales in Value Growth Rate (2017-2028) & (US$ Million)
    Figure 58. India Cancer Pain Sales in Value Growth Rate (2017-2028) & (US$ Million)
    Figure 59. Australia Cancer Pain Sales in Value Growth Rate (2017-2028) & (US$ Million)
    Figure 60. Taiwan Cancer Pain Sales in Value Growth Rate (2017-2028) & (US$ Million)
    Figure 61. Indonesia Cancer Pain Sales in Value Growth Rate (2017-2028) & (US$ Million)
    Figure 62. Thailand Cancer Pain Sales in Value Growth Rate (2017-2028) & (US$ Million)
    Figure 63. Malaysia Cancer Pain Sales in Value Growth Rate (2017-2028) & (US$ Million)
    Figure 64. Philippines Cancer Pain Sales in Value Growth Rate (2017-2028) & (US$ Million)
    Figure 65. Latin America Cancer Pain Sales in Volume Growth Rate 2017-2028 (K Units)
    Figure 66. Latin America Cancer Pain Sales in Value Growth Rate 2017-2028 (US$ Million)
    Figure 67. Mexico Cancer Pain Sales in Value Growth Rate (2017-2028) & (US$ Million)
    Figure 68. Brazil Cancer Pain Sales in Value Growth Rate (2017-2028) & (US$ Million)
    Figure 69. Argentina Cancer Pain Sales in Value Growth Rate (2017-2028) & (US$ Million)
    Figure 70. Middle East & Africa Cancer Pain Sales in Volume Growth Rate 2017-2028 (K Units)
    Figure 71. Middle East & Africa Cancer Pain Sales in Value Growth Rate 2017-2028 (US$ Million)
    Figure 72. Turkey Cancer Pain Sales in Value Growth Rate (2017-2028) & (US$ Million)
    Figure 73. Saudi Arabia Cancer Pain Sales in Value Growth Rate (2017-2028) & (US$ Million)
    Figure 74. U.A.E Cancer Pain Sales in Value Growth Rate (2017-2028) & (US$ Million)
    Figure 75. Cancer Pain Value Chain
    Figure 76. Cancer Pain Production Process
    Figure 77. Channels of Distribution
    Figure 78. Distributors Profiles
    Figure 79. Bottom-up and Top-down Approaches for This Report
    Figure 80. Data Triangulation
    Figure 81. Key Executives Interviewed